Images List Premium Download Classic

Lactobacillus

Lactobacillus-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Anti-bacterial lysate of probiotic bacteria
Skinbiotix Limited
July 13, 2017 - N°20170196919

The invention relates to probiotic bacteria and particularly, although not exclusively, to anti-bacterial compositions derived from probiotic bacteria. Disclosed are compositions comprising material secreted from probiotic bacteria, uses thereof, and methods using the compositions. Particularly contemplated are compositions comprising material secreted from lactobacillus rhamnosus, and uses thereof.
New strain of lactobacillus casei with ability to degrade the immunotoxic peptide from gluten
Consejo Superior De Investigaciones Cientificas (csic)
July 13, 2017 - N°20170196918

The invention relates to a bacterial strain, lactobacillus casei ipla12038 with deposit number cect 8590, and its use for the degradation of gluten, gliadin or derivative peptides. The strain has been isolated from an acidic dough used to make bread. Its advantages include the ability to use gliadin as nitrogen source, possess peptidase activities involved in the degradation of it and ...
Agent for prevention and treatment of chlamydia infection
Kabushiki Kaisha Yakult Honsha
July 13, 2017 - N°20170196917

An agent for the prevention and treatment of chlamydia infection containing lactobacillus casei as an active ingredient which is an agent for the prevention and treatment of chlamydia infection that is highly safe and that can be administered over an extended period of time.
Lactobacillus Patent Pack
Download + patent application PDFs
Lactobacillus Patent Applications
Download + Lactobacillus-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Lactobacillus-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods of use of novel strains of lactobacillus fermentum
Dairy A Day Inc.
June 29, 2017 - N°20170182101

Provided herein are novel lactobacillus fermentum strains, nrrl b-67059 or nrrl b-67060, compositions containing the nrrl b-67059 or nrrl b-67060 strains, and fermented dairy products and bioactive compounds prepared using the nrrl b-67059 or nrrl b-67060 strains. Also provided are methods of modulating the immune system of a subject.
Immune health for companion animals
Nestec Sa
June 22, 2017 - N°20170173138

The invention provides methods for promoting and/or improving immune health in a companion animal. In one embodiment, a method for improving immune health in a companion animal, comprising administering a composition comprising non-replicating lactobacillus paracasei to the companion animal, wherein the composition is administered in an amount effective for increasing immune response in the animal.
Treatment and prophylaxis for lupus
Nubiome, Inc.
June 22, 2017 - N°20170173088

An embodiment is a method of preventing, mitigating or treating lupus that includes administering an effective amount of a medicament to a human comprised of lactobacillus bulgaricus b-30892 and/or a supernatant resulting from culturing lactobacillus bulgaricus b-30892 and/or bioactive materials resulting from culturing lactobacillus bulgaricus b-30892 to prevent, mitigate or treat lupus.
Lactobacillus Patent Pack
Download + patent application PDFs
Lactobacillus Patent Applications
Download + Lactobacillus-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Lactobacillus-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel lactic acid bacteria and use thereof
New Bellus Enterprises Co., Ltd.
June 08, 2017 - N°20170157183

The present invention discloses novel lactic acid bacteria, which are isolated lactococcus lactis subsp. Lactis ll358 and isolated lactobacillus salivarius ls159 respectively. By administering the novel lactic acid bacteria of the present invention, renal injury, metabolic syndrome, hyperuricemia, hypocalcemia, and other disorders can be effectively ameliorated or treated.
Expression of a single chain antibody against salmonella in lactobacillus
New Bellus Enterprises Co., Ltd.
June 01, 2017 - N°20170152305

The present disclosure relates to camel id antibodies that inhibit growth, and colonization of salmonella serovars. The present disclosure also relates to a modified lactobacillus as a delivery vehicle for controlling salmonella in a host organism.
Lactic acid bacteria for coeliac disease
New Bellus Enterprises Co., Ltd.
May 25, 2017 - N°20170145379

The present invention discloses strains of lactobacillus and streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low ph and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
Formulation and treatment for acne
New Bellus Enterprises Co., Ltd.
May 25, 2017 - N°20170143776

The present invention relates to composition comprising lactobacillus rye ferment, dialkylisosorbide and phospholipid. Preferably, the composition further comprises ethoxylated sorbitan fatty acid ester. The composition has been shown to be effective against infections of closed comedones. The invention further relates to a method of preparing the composition, to a roll-on applicator comprising the composition and to the use of the ...
Novel lactobacillus paracasei strain
New Bellus Enterprises Co., Ltd.
May 18, 2017 - N°20170137902

Lactobacillus paracasei having polyamine production promoting activity in an organism.
Process for production and extraction of dihydrolipoic acid
Premier Research Labs, Lp
May 18, 2017 - N°20170137852

A process for production and extraction of dihydrolipoic acid (dhla) relates to the biotransformation of r-lipoic acid to dihydrolipoic acid. The process ferments the lipoic acid with bacteria selected from the genus of any of the following bacteria: lactobacillus, enterococcus, pediococcus, or bacillus. More particularly the present invention relates to a method for the extraction of dhla utilizing a non-traditional ...
Functional label, having lactobacillus separator membrane and using selective dissolution for detecting external temperature, for ...
Premier Research Labs, Lp
May 11, 2017 - N°20170131249

Provided is an exterior temperature-detectable selectively dissoluble lactic acid bacteria separation membrane functional label for checking freshness of a stored substance. More particularly, provided is an exterior temperature-detectable selectively dissoluble lactic acid bacteria separation membrane functional label for checking freshness of a stored substance which includes a lactic acid bacteria layer and a ph indicator layer that are attached to ...
Lactobacillus Patent Pack
Download + patent application PDFs
Lactobacillus Patent Applications
Download + Lactobacillus-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Lactobacillus-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
Asahi Group Holdings, Ltd.
May 04, 2017 - N°20170119828

This invention provides the use of a microorganism capable of improving both lipid metabolism and sugar metabolism. Specifically, the invention relates to: a lipid metabolism and/or sugar metabolism improver comprising, as an active ingredient, a bacterial cell selected from bacteria belonging to the genus lactobacillus and the genus bifidobacterium, a treated product of the bacterial cell, or a mixture ...
A composition for use in treating or preventing viral or bacterial infections in a subject ...
Asahi Group Holdings, Ltd.
April 27, 2017 - N°20170112883

A composition for use as adjunctive therapy to antitumor chemotherapeutic treatments, acquired immunodeficiency syndrome treatments and leukemia treatments is described. The composition includes a strain of bacteria lactobacillus reuteri lre 03 dsm 23879 which is able to strongly stimulate the production of pro-inflammatory cytokines (th1) interferon inf-gamma, the cytokines exhibiting a marked antiviral and/or antibacterial activity, and/or a bacterial strain ...
Composition containing bacterium belonging to genus lactobacillus
Suntory Holdings Limited
April 27, 2017 - N°20170112168

A composition containing a lactobacillus pentosus tua4337l strain (accession number: nite bp-1479), characterized in that the strain has proliferation ability in the small intestines and/or the large intestine, and preferably the small intestines, after having survived in the intestinal tract. Since the composition of the present invention contains lactic acid bacteria having proliferation ability in the intestinal tract, ...
Composition and method for maintaining healthy kidney function
Kibow Biotech, Inc.
April 20, 2017 - N°20170106029

A delayed-release composition composed of a lactobacillus bacterium, bifidobacterium longum, streptococcus thermophlus, inulin and xylooligosaccharide is provided for use in reducing nitrogenous waste products in the blood and treating renal failure.
In ovo delivery of probiotic cultures
Biogaia Ab
April 06, 2017 - N°20170095516

The present invention generally relates to a strain of lactobacillus probiotic bacteria and a poultry vaccine for use in the in ovo vaccination of poultry, wherein said strain and said vaccine are administered to an embryonated poultry egg. Compositions suitable for use in an in ovo vaccination protocol for poultry comprising a strain of lactobacillus probiotic bacteria and a vaccine ...
Naturally-occurring cpg oligonucleotide compositions and therapeutic applications thereof
Labyrinth Holdings, Llc
March 30, 2017 - N°20170087247

The present invention relates to combination therapies for the treatment of a variety of disorders in mammals, including hepatic disorders and cancer. The combination of agents includes naturally-occurring (versus synthetic) oligonucleotides, particularly immunostimulatory oligodeoxynucleotides such as cpg odns, obtained from a natural source and one or more extracts from a gram positive bacteria, such as lactobacillus spp.
Creped prebiotic tissue
Kimberly-clark Worldwide, Inc.
March 23, 2017 - N°20170080105

The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile strength, stiffness or softness. Thus, in certain embodiments the present invention provides soft, durable creped prebiotic tissue products that are able to improve the growth of healthy ...
Lactobacillus composition allowing the stimulation of human and animal juvenile growth in cases of malnutrition
Centre National De La Recherche Scientifique
March 23, 2017 - N°20170080034

The invention relates to a pharmaceutical or probiotic composition comprising at least one lactobacillus strain with intestinal tropism, especially selected from the species lactobacillus plantarum, lactobacillus fermentum and lactobacillus casei, used to stimulated juvenile growth in cases of malnutrition especially characterised by a protein deficiency. The strains can be selected from a vinegar fly model and/or a mouse model. ...
Loading